223 related articles for article (PubMed ID: 35121728)
1. PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4/ERK signaling pathway and accelerating glycolysis.
He Y; Wang X; Lu W; Zhang D; Huang L; Luo Y; Xiong L; Li H; Zhang P; Li Q; Liang S
Cell Death Dis; 2022 Feb; 13(2):118. PubMed ID: 35121728
[TBL] [Abstract][Full Text] [Related]
2. Novel inhibitors targeting the PGK1 metabolic enzyme in glycolysis exhibit effective antitumor activity against kidney renal clear cell carcinoma in vitro and in vivo.
He Y; Luo Y; Huang L; Zhang D; Hou H; Liang Y; Deng S; Zhang P; Liang S
Eur J Med Chem; 2024 Mar; 267():116209. PubMed ID: 38354523
[TBL] [Abstract][Full Text] [Related]
3. Activation of PGK1 under hypoxic conditions promotes glycolysis and increases stem cell‑like properties and the epithelial‑mesenchymal transition in oral squamous cell carcinoma cells via the AKT signalling pathway.
Zhang Y; Cai H; Liao Y; Zhu Y; Wang F; Hou J
Int J Oncol; 2020 Sep; 57(3):743-755. PubMed ID: 32705252
[TBL] [Abstract][Full Text] [Related]
4. Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancer.
Zieker D; Königsrainer I; Tritschler I; Löffler M; Beckert S; Traub F; Nieselt K; Bühler S; Weller M; Gaedcke J; Taichman RS; Northoff H; Brücher BL; Königsrainer A
Int J Cancer; 2010 Mar; 126(6):1513-20. PubMed ID: 19688824
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis.
Li X; Jiang Y; Meisenhelder J; Yang W; Hawke DH; Zheng Y; Xia Y; Aldape K; He J; Hunter T; Wang L; Lu Z
Mol Cell; 2016 Mar; 61(5):705-719. PubMed ID: 26942675
[TBL] [Abstract][Full Text] [Related]
6. Macrophage-Associated PGK1 Phosphorylation Promotes Aerobic Glycolysis and Tumorigenesis.
Zhang Y; Yu G; Chu H; Wang X; Xiong L; Cai G; Liu R; Gao H; Tao B; Li W; Li G; Liang J; Yang W
Mol Cell; 2018 Jul; 71(2):201-215.e7. PubMed ID: 30029001
[TBL] [Abstract][Full Text] [Related]
7. PTEN Suppresses Glycolysis by Dephosphorylating and Inhibiting Autophosphorylated PGK1.
Qian X; Li X; Shi Z; Xia Y; Cai Q; Xu D; Tan L; Du L; Zheng Y; Zhao D; Zhang C; Lorenzi PL; You Y; Jiang BH; Jiang T; Li H; Lu Z
Mol Cell; 2019 Nov; 76(3):516-527.e7. PubMed ID: 31492635
[TBL] [Abstract][Full Text] [Related]
8. PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis.
Liu H; Chen X; Wang P; Chen M; Deng C; Qian X; Bai J; Li Z; Yu X
Cell Death Dis; 2024 Feb; 15(2):170. PubMed ID: 38402202
[TBL] [Abstract][Full Text] [Related]
9. GBP1 promotes erlotinib resistance via PGK1‑activated EMT signaling in non‑small cell lung cancer.
Cheng L; Gou L; Wei T; Zhang J
Int J Oncol; 2020 Sep; 57(3):858-870. PubMed ID: 32582960
[TBL] [Abstract][Full Text] [Related]
10. Roles and mechanisms of phosphoglycerate kinase 1 in cancer.
Chen Y; Cen L; Guo R; Huang S; Chen D
Bull Cancer; 2022 Dec; 109(12):1298-1307. PubMed ID: 36096942
[TBL] [Abstract][Full Text] [Related]
11. PGK1 : An Essential Player in Modulating Tumor Metabolism.
Duncan L; Shay C; Teng Y
Methods Mol Biol; 2022; 2343():57-70. PubMed ID: 34473315
[TBL] [Abstract][Full Text] [Related]
12. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH
Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215
[TBL] [Abstract][Full Text] [Related]
13. Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesis.
Hu H; Zhu W; Qin J; Chen M; Gong L; Li L; Liu X; Tao Y; Yin H; Zhou H; Zhou L; Ye D; Ye Q; Gao D
Hepatology; 2017 Feb; 65(2):515-528. PubMed ID: 27774669
[TBL] [Abstract][Full Text] [Related]
14. A novel inhibitor of PGK1 suppresses the aerobic glycolysis and proliferation of hepatocellular carcinoma.
Li M; Zhang A; Qi X; Yu R; Li J
Biomed Pharmacother; 2023 Feb; 158():114115. PubMed ID: 36516697
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.
Zheng N; Liu W; Li B; Nie H; Liu J; Cheng Y; Wang J; Dong H; Jia L
J Exp Clin Cancer Res; 2019 May; 38(1):232. PubMed ID: 31151472
[TBL] [Abstract][Full Text] [Related]
16. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
[TBL] [Abstract][Full Text] [Related]
17. CPT2-mediated fatty acid oxidation inhibits tumorigenesis and enhances sorafenib sensitivity via the ROS/PPARγ/NF-κB pathway in clear cell renal cell carcinoma.
Zeng K; Li Q; Song G; Chen B; Luo M; Miao J; Liu B
Cell Signal; 2023 Oct; 110():110838. PubMed ID: 37541641
[TBL] [Abstract][Full Text] [Related]
18. PGK1 facilities cisplatin chemoresistance by triggering HSP90/ERK pathway mediated DNA repair and methylation in endometrial endometrioid adenocarcinoma.
Zhou JW; Tang JJ; Sun W; Wang H
Mol Med; 2019 Mar; 25(1):11. PubMed ID: 30925862
[TBL] [Abstract][Full Text] [Related]
19. Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma.
Wang J; Chang H; Su M; Qiao Y; Sun H; Zhao Y; Zhang S; Shan C
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562974
[TBL] [Abstract][Full Text] [Related]
20. ORM1 promotes tumor progression of kidney renal clear cell carcinoma (KIRC) through CALR-mediated apoptosis.
Yu G; Gao J; Hu W; Hu D; Wang W; Yang S; Gao J
Sci Rep; 2023 Sep; 13(1):15687. PubMed ID: 37735575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
